What You Should Know:
- Abbott announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization.
- The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
- Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
- SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More
Streamlining Biospecimen Procurement: Avoid These 8 Common R&D Mistakes
Long before a clinician administers a drug or runs a new test, there is the arduous R&D cycle. Unfortunately, it’s rarely as streamlined as the one that just delivered COVID-19 vaccines in record-shattering time.
For most Americans, vaccines and drugs seem to spring wholly formed from clinical trials, which are becoming part of America’s everyday conversation. But before any vaccine or therapy hits the market, the less-visible pre-clinical research and development must be performed – from
Read More
Syneos, Medable Team Up to Bring Decentralized Clinical Trials to Patients
What You Should Know:
- Syneos Health, a fully integrated biopharmaceutical solutions organization, and Medable, a cloud platform for patient-centered drug development, announced a strategic partnership to bring clinical trials closer to the patient.
- The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
- As part
Read More
Google Cloud Expands Intelligent Vaccine Impact Solution to Support Vaccine Equity
What You Should Know:
- Google Cloud today launched an expanded virtual agent as part of its Intelligent Vaccine Impact solution (IVIs). People will be able to schedule vaccine appointments and ask common questions through a virtual agent, Contact Center AI.
- Contact Center AI (CCAI), one core component of the Intelligent Vaccine Impact solution, scales call center human operations with intelligent virtual agents that understand, interact and can talk with people 24/7 in real-time,
Read More
C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform
- Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others.
- Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service, that uses AI pattern recognition and whole-genome analysis to provide rapid and cancer-specific detection of residual disease 100x more sensitive than
Read More
Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development
What You Should Know:
- Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures.
- This is
Read More
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and effectively and was complicated by the reality that trials often deal with the populations most at risk from COVID-19 exposure1.
In response, clinical researchers turned to a range of
Read More
Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform
- Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global expansion to support enterprise customers. The raise is also joined by existing investors Thrive Capital, Benchmark, Menlo Ventures, Alkeon Capital, ICONIQ, Lux Capital, Spark Capital, and Lead Edge Capital.
-
Read More
Komodo Health Launches Next-Gen AI to Accelerate Innovation and Close Gaps in Care
What You Should Know:
- Today, Komodo Health is capping off a month-long flurry of activity by announcing the launch of its Prism and Sentinel solutions — opening up access to its Healthcare Map to drive the next generation of AI innovation.
- Prism and Sentinel allows life sciences teams to tap into detailed patient behaviors and treatment patterns based on the real-world patient journeys of more than 325 million patients. The breakthrough software also allows life sciences teams to
Read More
